Oncolytics Biotech Inc. (ONCY) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Oncolytics Biotech Inc. (ONCY) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $90.3M, listed on NASDAQ, employing roughly 28 people, carrying a beta of 1.03 to the broader market. Oncolytics Biotech Inc. Led by Jared Kelly, public since 2001-10-05.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for ONCY as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →